MR编号 | SE/H/0171/001 |
---|
药品名称 | Hemosol B0 |
---|
活性成分 | - [No Active-Substance specified] 0.0 -
|
---|
剂型 | Solution for haemodialysis/haemofiltration |
---|
上市许可持有人 | Baxter Holding B.V. Netherlands |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Luxembourg (LU)
- Iceland (IS)
- Norway (NO)
- Poland (PL)
- Latvia (LV)
Hemosol B0 šķīdums hemofiltrācijai un hemodialīzei - Lithuania (LT)
Hemososl B0 hemodializės/hemofiltracijos tirpalas - Estonia (EE)
HEMOSOL B0 - Bulgaria (BG)
Hemosol - Cyprus (CY)
HEMOSOL B0 SOLUTION FOR HAEMOFILTRATION - Czechia (CZ)
Hemosol B0 - Slovakia (SK)
Hemosol BO - Malta (MT)
- Germany (DE)
Hemosol B0 - Slovenia (SI)
- Denmark (DK)
- Belgium (BE)
- United Kingdom (Northern Ireland) (XI)
Hemosol B0 - Ireland (IE)
- Austria (AT)
Hemosol BO Lösung für Hämofiltration und Hämodialyse - France (FR)
Hemosol - Spain (ES)
- Greece (GR)
- Finland (FI)
Hemosol B0 - Portugal (PT)
- Croatia (HR)
- Netherlands (NL)
|
---|
许可日期 | 1999/05/04 |
---|
最近更新日期 | 2024/06/19 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Bibliographic Article 4.8 (a) (ii)
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|